News, Analysis, Trends, Management Innovations for
Clinical Laboratories and Pathology Groups

Hosted by Robert Michel

News, Analysis, Trends, Management Innovations for
Clinical Laboratories and Pathology Groups

Hosted by Robert Michel
Sign In

Clinical Pathology Laboratories Should Expect More Direct-to-Consumer Testing

QuickCheck Health offers care delivery model that marries DTC diagnostic tests with physician review and follow-up

In an interesting twist on the direct-to- consumer (DTC) diagnostic testing market, QuickCheck Health (QCH) is developing a DTC testing platform that brings clinician oversight into the process.

Most pathologists and clinical laboratory managers know that over-the-counter (OTC) testing is one of the faster growing market segment of in vitro diagnostics. A number of OTC products—including tests for urinary tract infections, pregnancy, ovulation, fertility, HIV, and other conditions—are already on the market, stated an article in Technology Review.

However, the existing direct-to-consumer testing model has at least two drawbacks. First, treatment or follow-up care for these DTC tests requires a visit to the doctor. Second, most physicians are reluctant to treat with medication without validating the DTC test results generated by patient self-testing.

(more…)

;